Approved

Latest episodes

Showing 5 · updated from the feed

What is Approved?

Approved tells the definitive stories behind the world's most interesting biotech ventures. Most people learn about the industry in a fragmented, ad hoc way-- an indust

Sep 14
3 min

Blueprint Medicines: Chasing Gleevec to a $9B Allergy Drug

Blueprint Medicines was built to find the next Gleevec-style cancer drug. It ended up pivoting to allergic disease instead, and selling to Sanofi for $9B. This is the pla

Aug 4
2 h 29 min

Keytruda: How Merck's Pembrolizumab Became the Best-Selling Cancer Drug of All Time

Keytruda is Merck's $31 billion a year PD-1 inhibitor and the best-selling cancer drug of all time. In Episode 3 of Approved, Alex Kesin and Matthew Pech trace the develo

May 14
2 h 07 min

Episode #2: Geron

Listen on Spotify Listen on Apple Podcasts Listen on YouTube TABLE OF CONTENTS (00:00:00) - Introduction (00:01:19) - Hayflick Limit (00:08:30) - Michael West & F

Mar 13
2 h 22 min

Episode #1: Amylin Pharmaceuticals

Listen on Spotify Listen on Apple Podcasts Listen on YouTube TABLE OF CONTENTS (00:00:00) - Introduction (00:04:40) - $50 of Dried Lizard Venom (00:29:17) - Fax of

Jan 30
1 h 46 min

Chart trend

Position in the Life Sciences chart (US), last 90 days.

#1#53#105JulAugSep

#13

all-time peak

53

days in the top 50 since Jul 2026

Chart positions

Where Approved ranks today in each Apple Podcasts chart (US, Sep 17, 2026).

#48 ▲ 3 Life Sciences US

What listeners say

A curated, balanced selection of Apple Podcasts reviews.

Where others interview today's CEO about tomorrow's pipeline, they examine what actually happened and why it mattered. They go back to primary sources — patents, SEC filings, clinical records — to reconstruct the origin story and the critical decisions that shaped it. Best Biotech Podcast to learn the ins and outs of the industry. Highly recommend it.

mevesavard · Apr 2026

We strive to present a balanced view by showing a diverse range of reviews from Apple Podcasts.